Navigation Links
Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections
Date:11/24/2008

--PS-Targeting AntibodiesMay Represent a Completely New Class of Drugs with Broad Potential to Treat Life-Threatening Viral Infections--

--Peregrine's Clinical-Stage Anti-PS Agent Bavituximab and Equivalent Antibodies Cured Lethal Viral Infections in Preclinical Models--

--Data Confirms PS is a 'Druggable' Target Common to a Number of Serious Viral Infections--

TUSTIN, Calif., Nov. 24 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq:PPHM) today reported publication of data in Nature Medicine that supports the broad anti-viral potential of the company's novel anti-phosphatidylserine (anti-PS) antibody platform, showing that its PS-targeting drug bavituximab can cure lethal virus infections in animal disease models.

Bavituximab is in clinical trials for the treatment of hepatitis C virus (HCV) infection and in preclinical development for the treatment of viral hemorrhagic fevers under a contract worth up to $44.4 million with the bioterrorism program of the U.S. Defense Threat Reduction Agency (DTRA). Bavituximab and other anti-PS antibodies are also being studied preclinically in HIV, cytomegalovirus (CMV) and other serious viral infections.

"Based on these findings, anti-PS antibodies such as bavituximab may represent a completely new class of drugs for the treatment of life-threatening viral infections," said study co-author Dr. Philip Thorpe, professor of pharmacology at UT Southwestern Medical Center and a scientific advisor to Peregrine. "By targeting a property of the host cell rather than the virus itself, anti-PS antibodies have the potential to treat a range of viral infections, and they should be less susceptible to the viral mutations that contribute to the development of drug resistance."

In the research reported today, scientists at UT Southwestern assessed the activity of bavituximab in animal
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. First Study of War-Related Mental Disorders Among Iraqis 10 Years Post-Gulf War Published by Researchers at Wayne State University and Basrah University, Iraq
2. Long-Term Results of VisionCares Implantable Telescope for End-Stage Macular Degeneration Published in the American Journal of Ophthalmology
3. Results From Pre-Election Surveys Published in NEJM Show Deep Concerns About State of Health Care With McCain and Obama Supporters Differing Sharply on Directions for New Administration
4. Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis
5. International Implementation of Breast Health Guidelines for Developing Countries Published by Cancer
6. MultiVu Video Feed: NEW RESEARCH PUBLISHED IN THE AMERICAN JOURNAL OF CLINICAL NUTRITION FINDS PISTACHIOS IMPROVE RISK FACTORS FOR HEART DISEASE
7. McCulley/Cuppan Consultants Contribute Chapter to the Newly Published Book, Rhetoric of Healthcare: Essays Toward a New Disciplinary Inquiry
8. Notice of Proposed Rulemaking on U.S. Department of Labors Risk Assessment Procedures Published in Federal Register
9. Positive Findings Published on Emergent Technology for Treating Chronic Pain
10. Study Published in JAMA on RFID Interference Ignores Real-World Use Cases, According to SkyeTek
11. Data Published in Anticancer Research Show ChemoFx(R) Assay Results Correlate With Outcomes in Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)AVIVA today announced the launch of International Solutions, an innovative new international private medical insurance plan which follows the acclaimed modular design of its UK equivalent. In addition
(Date:12/4/2009)NEW YORK, Dec. 4 Thousands of KPMG LLP employees came together in more than 90 offices nationwide today, to participate in a community service event which combines the audit, tax and advisory firm,s
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)Rockville, MD "Why is it that men can be bastards and women must wear pearls and smile?" wrote author Lynn Hecht Schafran. The answer, according to an article in the Journal of Vision , may lie in
Breaking Medicine News(10 mins):Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Are angry women more like men? 2
...ck claims status, rate doctors and ...0 Regence,s innovative Web site,that allows membe...r doctor,and earn gift certificates for participat... 2,400 Web sites representing 47 countries in 96 c...
... Service Provider Grows 352%, ATLANTA, Sept. 30 ...lth care business process outsourcing, today annou...of the fastest-growing privately held,companies in... companies that made the list reported aggregate r...
...perability Requirements, SUNNYVALE, Calif., Sept....nformation Technology (CCHIT(R)) today announced,t... Certified(R) 08,Ambulatory EHR and meets the Cert...ere most Americans get their,healthcare. The Commi...
...han Two Lbs. Folds Flat For Easy ... 30 Committed to,providing smart, easy fitness so...o, Perfect Pushup, LLC ( http://www.perfectpushup....eled after the,successful Perfect Pushup unit that...
...LC, a professional software development firm, toda...Analyst, an innovative and full-featured Contract ... more intuitive look and feel User Interface; Extr...ch any table on any lookup item, date ranges, and ...
...004 petition from,the Beverage Institute for Healt...-Cola Company (NYSE: KO ), the US Food and Drug A...ended its osteoporosis risk reduction health,claim...nition of the populations that could benefit from ...
Other Medicine News:Health News:myRegence.com Earns Best Health Care Industry Web Site Award 2Health News:RevenueMed Named to Inc. 5000 2Health News:MedPlexus Electronic Health Record Receives 08 CCHIT Certification 2Health News:MedPlexus Electronic Health Record Receives 08 CCHIT Certification 3Health News:MedPlexus Electronic Health Record Receives 08 CCHIT Certification 4Health News:Perfect Pushup Introduces Innovative Travel Fitness Solution; Mobile Unit Designed for Travelers Hits Retail This Month 2Health News:TrakSoft LLC Announces the Release of Contract Analyst, Version 3.0, a Contract Management System, which Includes a Major User Customization Upgrade 2Health News:TrakSoft LLC Announces the Release of Contract Analyst, Version 3.0, a Contract Management System, which Includes a Major User Customization Upgrade 3Health News:TrakSoft LLC Announces the Release of Contract Analyst, Version 3.0, a Contract Management System, which Includes a Major User Customization Upgrade 4Health News:Vitamin D Added to FDA Osteoporosis Risk-Reduction Health Claim 2Health News:Vitamin D Added to FDA Osteoporosis Risk-Reduction Health Claim 3Health News:Vitamin D Added to FDA Osteoporosis Risk-Reduction Health Claim 4
(Date:12/4/2009)OMAHA, Neb., Dec. 4 Amber Pharmacy announced today that it received accreditation by the Accreditation Commission for Health Care, Inc. (ACHC) for specialized pharmacy services. For nearly 15 years,
(Date:12/4/2009)STREAMWOOD, Ill., Dec. 4 Shared Imaging, LLC, an independent provider of CT, MRI and PET/CT systems and service programs for hospitals and healthcare providers, is excited to announce it has received
(Date:12/4/2009)Opposes use of imported drugs often stored in tin cans and car trunks ,, WASHINGTON, Dec. 4 Today, the senior advocacy group RetireSafe urged the Senate to defeat the Dorgan Importation plan encomp
Breaking Medicine Technology:Amber Pharmacy Earns Accreditation From ACHC 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications 13231 1Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications 13231 2Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications 13231 3Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications 13231 4Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications 13231 5Common household pesticides linked to childhood cancer cases in Washington area 52920 1Common household pesticides linked to childhood cancer cases in Washington area 52920 2Biologists rediscover endangered frog population 9389 1Biologists rediscover endangered frog population 9389 2Biologists rediscover endangered frog population 9389 3Biologists rediscover endangered frog population 9389 4
...Was Sustained and Dose-Dependent in Sub-Analysis o...ial, ORLANDO, Fla., Nov. 7 SCH 530348 (TRA), the...opment by Schering-Plough,Corporation (NYSE: SGP ...aggregation in a sub-analysis of the Thrombin Rece...on (TRA-PCI) trial presented today at the,American...
... Pa., and LYON, France, Nov. 7 ,Sanofi Pasteur, th...nced,today that it has initiated Phase II testing ...ne in the U.S. The initiation of Phase I was anno...contract awarded in 2005 by the U.S. Department of...ting the development of a new cell,culture- based ...
Other Medicine Technology:SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients 2SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients 3SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients 4SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients 5SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients 6SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients 7Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine 2Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine 3Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine 4
Sterile Suction Catheters without Control Valve
AirLife™ Brand Tri-Flo® Single Catheters
Tracheal Suction Latex Rubber Catheters - DeLee Tip
...00 Corneal Topographer is the result of years of r...oduct innovation and value, continues to bring you...rumentation. The CT 200 is faster and easier to us...The CT 200 is the latest innovation in detailed ey...
Medicine Products: